{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T16:40:05Z","timestamp":1776616805989,"version":"3.51.2"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,19]]},"DOI":"10.7759\/cureus.107344","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T15:52:16Z","timestamp":1776613936000},"source":"Crossref","is-referenced-by-count":0,"title":["Cross-Sectional Study to Compare Sentinel Lymph Node Biopsy vs. Complete Axillary Lymph Node Dissection for the Evaluation of Lymph Node Metastasis in Females With Locally Advanced Breast Carcinoma Post Neoadjuvant Chemotherapy"],"prefix":"10.7759","author":[{"given":"Rahul","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fareed","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhay K","family":"Brahamane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oshin","family":"Chhipa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"35","author":"Loibl S","year":"2024","unstructured":"Loibl S, Andr\u00e9 F, Bachelot T, et al.. Early breast cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024, 35:159-82. 10.1016\/j.annonc.2023.11.016","journal-title":"Ann Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3492","article-title":"Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis","volume":"26","author":"Spring LM","year":"2020","unstructured":"Spring LM, Fell G, Arfe A, et al.. Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis. Clin Cancer Res. 2020, 26:2838-48. 10.1158\/1078-0432.CCR-19-3492","journal-title":"Clin Cancer Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70076-7","article-title":"Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis","volume":"14","author":"DiSipio T","year":"2013","unstructured":"DiSipio T, Rye S, Newman B, et al.. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013, 14:500-5. 10.1016\/S1470-2045(13)70076-7","journal-title":"Lancet Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn T","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, et al.. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013, 14:609-18. 10.1016\/S1470-2045(13)70166-9","journal-title":"Lancet Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau JF","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M, et al.. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015, 33:258-64. 10.1200\/JCO.2014.55.7827","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2021.07.015","article-title":"Feasibility and reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive axillary nodes at initial diagnosis: an up-to-date meta-analysis of 3,578 patients","volume":"59","author":"Cao S","year":"2021","unstructured":"Cao S, Liu X, Cui J, et al.. Feasibility and reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive axillary nodes at initial diagnosis: an up-to-date meta-analysis of 3,578 patients. Breast. 2021, 59:256-69. 10.1016\/j.breast.2021.07.015","journal-title":"Breast"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70278-4","article-title":"Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial","volume":"8","author":"Krag DN","year":"2007","unstructured":"Krag DN, Anderson SJ, Julian TB, et al.. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007, 8:881-8. 10.1016\/S1470-2045(07)70278-4","journal-title":"Lancet Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21535","article-title":"Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection","volume":"102","author":"Ashikaga T","year":"2010","unstructured":"Ashikaga T, Krag DN, Land SR, et al.. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol. 2010, 102:111-8. 10.1002\/jso.21535","journal-title":"J Surg Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano AE","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, et al.. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011, 305:569-75. 10.1001\/jama.2011.90","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano AE","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, et al.. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017, 318:918-26. 10.1001\/jama.2017.11470","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti V","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, et al.. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 2013, 14:297-305. 10.1016\/S1470-2045(13)70035-4","journal-title":"Lancet Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker M","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, et al.. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014, 15:1303-10. 10.1016\/S1470-2045(14)70460-7","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-00099","article-title":"Sentinel lymph node biopsy in early-stage breast cancer: ASCO guideline update","volume":"43","author":"Park KU","year":"2025","unstructured":"Park KU, Somerfield MR, Anne N, et al.. Sentinel lymph node biopsy in early-stage breast cancer: ASCO guideline update. J Clin Oncol. 2025, 43:1720-41. 10.1200\/JCO-25-00099","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer. The ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey JC","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, et al.. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer. The ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013, 310:1455-61. 10.1001\/jama.2013.278932","journal-title":"JAMA"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/473141-cross-sectional-study-to-compare-sentinel-lymph-node-biopsy-vs-complete-axillary-lymph-node-dissection-for-the-evaluation-of-lymph-node-metastasis-in-females-with-locally-advanced-breast-carcinoma-post-neoadjuvant-chemotherapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T15:52:17Z","timestamp":1776613937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/473141-cross-sectional-study-to-compare-sentinel-lymph-node-biopsy-vs-complete-axillary-lymph-node-dissection-for-the-evaluation-of-lymph-node-metastasis-in-females-with-locally-advanced-breast-carcinoma-post-neoadjuvant-chemotherapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,19]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.107344","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,19]]}}}